Recent advances in high-throughput nucleic acid sequencing of human cancers brought to the forefront the tremendous complexity and plasticity of RNA metabolism, which includes alternative splicing and polyadenylation, editing, transcription of non-coding parts of genome, extensive gene regulation by both lncRNAs and microRNAs, and so on. Far from being mere by-products of errant transcription, these events emerge as key players in and biomarkers of cancer pathogenesis, progression, and resistance to therapy. Recognizing the importance of RNA metabolism for human cancers, the Tumor Biology Program of the Penn Medicine’s Abramson Cancer Center is organizing this one-day symposium on “RNA Biology and Cancer”, featuring both internal and external speakers.

Program             Registration            Abstract Submission